FDA approves low-dose spinal cord stimulator for chronic pain
Abbott has received FDA approval for its Proclaim XR recharge-free neurostimulation system for people with chronic pain. A press release reports that the Proclaim...
Axonics announces agreement to supply sacral neuromodulation systems to leading urology practice group
Axonics has announced that it has entered into an exclusive agreement to supply the Axonics rechargeable sacral neuromodulation (r-SNM) system to Adult Pediatric Urology...
LivaNova enrols first patient in RECOVER clinical study
LivaNova has announced the first patient enrolled in their RECOVER trial, a prospective, multi-centre, randomised controlled blinded trial demonstrating the safety and effectiveness of...
The Brainstorms Scientific set to host Europe’s first transdisciplinary neuroscience festival
The Brainstorms Scientific are launching the Brainstorms Festival, a two-day business and human-orientated technology event set to take place in Vienna, Austria, on 27–28...
